Feed NUZ.AX
NU
Neurizon Therapeutics Limited
NUZ.AX · ASX
$0.06 +1.64% (+$0.00)
1M -1.59%
Market Cap $47.3M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.03
51.6% downside
Preț actual
$0.062
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NUZ.AX sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
0 /100
Expensive P/B 16.76x
PEG N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 28.89%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 653.88%
ROA 380.70%
Debt
100 /100
Low Current ratio 2.84x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 0
Beta 1.31x
EPS volatility 127.70%
Întreabă StockBot despre NUZ.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ben Dingle
Employees
36
Headquarters
Melbourne